See more : CTCI Advanced Systems Inc. (5209.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Kenvue Inc. (KVUE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kenvue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Dingyi Group Investment Limited (0508.HK) Income Statement Analysis – Financial Results
- DigitalTown, Inc. (DGTW) Income Statement Analysis – Financial Results
- LEEP, Inc. (LPPI) Income Statement Analysis – Financial Results
- Aims Property Securities Fund (APW.AX) Income Statement Analysis – Financial Results
- DaTang HuaYin Electric Power Co., LTD (600744.SS) Income Statement Analysis – Financial Results
Kenvue Inc. (KVUE)
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 15.44B | 14.95B | 15.05B | 14.47B | 14.32B |
| Cost of Revenue | 6.80B | 6.67B | 6.64B | 6.62B | 6.66B |
| Gross Profit | 8.64B | 8.29B | 8.42B | 7.85B | 7.66B |
| Gross Profit Ratio | 55.96% | 55.42% | 55.93% | 54.25% | 53.49% |
| Research & Development | 399.00M | 375.00M | 355.00M | 320.00M | 391.00M |
| General & Administrative | 4.33B | 4.28B | 4.02B | 3.73B | 3.94B |
| Selling & Marketing | 1.35B | 1.36B | 1.46B | 1.23B | 1.26B |
| SG&A | 5.68B | 5.63B | 5.48B | 4.96B | 5.20B |
| Other Expenses | 50.00M | 4.00M | 25.00M | 3.00M | 59.00M |
| Operating Expenses | 6.13B | 5.62B | 5.41B | 4.86B | 5.26B |
| Cost & Expenses | 12.93B | 12.28B | 12.04B | 11.48B | 11.93B |
| Interest Income | 108.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 358.00M | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 627.00M | 644.00M | 731.00M | 746.00M | 709.00M |
| EBITDA | 3.18B | 3.64B | 3.87B | 3.79B | 3.28B |
| EBITDA Ratio | 20.56% | 22.39% | 25.61% | 53.51% | 25.98% |
| Operating Income | 2.51B | 2.68B | 2.92B | -979.00M | 1.85B |
| Operating Income Ratio | 16.27% | 17.89% | 19.40% | -6.77% | 12.89% |
| Total Other Income/Expenses | -322.00M | -38.00M | 5.00M | -37.00M | 274.00M |
| Income Before Tax | 2.19B | 2.64B | 2.93B | -1.02B | 2.12B |
| Income Before Tax Ratio | 14.18% | 17.64% | 19.43% | -7.02% | 14.80% |
| Income Tax Expense | 526.00M | 550.00M | 894.00M | -137.00M | 685.00M |
| Net Income | 1.66B | 2.06B | 2.08B | -879.00M | 1.44B |
| Net Income Ratio | 10.77% | 13.81% | 13.80% | -6.08% | 10.02% |
| EPS | 0.90 | 1.08 | 1.08 | -0.47 | 0.76 |
| EPS Diluted | 0.87 | 1.08 | 1.08 | -0.47 | 0.76 |
| Weighted Avg Shares Out | 1.85B | 1.91B | 1.89B | 1.89B | 1.89B |
| Weighted Avg Shares Out (Dil) | 1.92B | 1.91B | 1.89B | 1.89B | 1.89B |
Kenvue gains on reports activist investor Starboard Value has taken ‘sizeable' stake
Starboard Value Buys Into Dow Jones Spinoff; Elf Beauty Rallies
Tylenol Maker Kenvue Stock Surges on Report Starboard Takes 'Sizable Stake'
Kenvue shares surge after activist Starboard takes stake
Starboard Targets Another Health Company. Why Kenvue Is in Its Sights.
Starboard reportedly takes big stake in Tylenol maker Kenvue
Activist investor Starboard Value takes stake in consumer products maker Kenvue, sources say
Activist Starboard Value Takes Stake in Tylenol-Maker Kenvue
Kenvue to Announce Third Quarter 2024 Results on November 7, 2024
Analysts Estimate Kenvue (KVUE) to Report a Decline in Earnings: What to Look Out for
Source: https://incomestatements.info
Category: Stock Reports